↓ Skip to main content

Angiogenesis inhibitors for the treatment of ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, September 2011
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Angiogenesis inhibitors for the treatment of ovarian cancer
Published in
Cochrane database of systematic reviews, September 2011
DOI 10.1002/14651858.cd007930.pub2
Pubmed ID
Authors

Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum, Jo Morrison

Abstract

Many women with ovarian cancer eventually develop resistance to conventional chemotherapy drugs, and so novel agents are being developed to target specific molecular pathways. One such class of drugs inhibits angiogenesis (the development of new blood vessels), which is essential for tumour growth. It is important to establish whether the addition of these new drugs to conventional chemotherapy regimens improves survival, and what the side-effects may be.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 2 2%
Italy 1 1%
Spain 1 1%
Unknown 88 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 21%
Student > Master 16 17%
Student > Ph. D. Student 16 17%
Student > Bachelor 13 14%
Unspecified 11 12%
Other 17 18%
Readers by discipline Count As %
Medicine and Dentistry 52 57%
Unspecified 13 14%
Agricultural and Biological Sciences 9 10%
Nursing and Health Professions 4 4%
Computer Science 3 3%
Other 11 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2011.
All research outputs
#9,618,848
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,200
of 8,923 outputs
Outputs of similar age
#69,142
of 90,718 outputs
Outputs of similar age from Cochrane database of systematic reviews
#41
of 49 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,718 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.